Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions encompass a variety of studies and clinical trials, such as references to the findings from the KDIGO Controversies Conference and ongoing clinical trials involving medications like Semaglutide. Phrases such as 'significant insights' and 'impressive results' reflect a tone of optimism and urgency about the need for better understanding and management of obesity-related kidney disease, which strengthens the overall sentiment of high interest and perceived impact.
The majority of discussions express support for the findings related to the connection between obesity and chronic kidney disease, indicating a consensus on the importance of the topic.
There is a notable enthusiasm around this subject, with many users actively engaging and sharing related studies and trials, suggesting a high level of intrigue.
While some discussions are more informational, several users delve deeply into specific studies and methods, reflecting an interest in the implications of the research.
Many contributors perceive the publication as highly impactful, emphasizing its relevance to current health issues, and discussing its potential to influence future treatment strategies.
The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney International https://t.co/wM1aZwV3To @SENefrologia well represented with @beaff26 @Emor67 #Porrini & @PepaSolerR /// @SLANH_ with @jorgericof & others
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes Controversies Conference
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial: @PepaSolerR @jlgorriz @crz_garrit @chuspuchades @Heerspink79
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial | @NatureMedicine by Hiddo https://t.co/z6Sl1PME41
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial 非糖尿病の肥満CKD患者に対するSemaglutideの効果をみたRCT @NatureMedicine (2024) https://t.co/1Ymq35NFUI
Obesity rates have significantly increased since 1975, leading to a major health crisis. This video explores the relationship between obesity and the progression of chronic kidney disease (CKD), highlighting symptoms…
Obesity rates have significantly increased, tripling since 1975, creating a health crisis related to chronic kidney disease (CKD). This video explores how glomerulomegaly and microproteinuria manifest in obesity-related…
RT @jcrm_MDPI: We invite you to read the recently published review "Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanism…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
We invite you to read the recently published review "Obesity and Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Impact, and Management Strategies" by Dr. Pallavi Shirsat et al. Link: https://t.co/KQ1SUxbZsy
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @MarkusAtHome: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcome…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @MarkusAtHome: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcome…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
Impact of Bariatric Metabolic Surgery on Cardiovascular, Kidney, and Mortality Outcomes Among Adults with Obesity and Chronic Kidney Disease Across Different Time Frames
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
RT @PepaSolerR: The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney Inter…
The relationship between obesity and chronic kidney disease: Conclusions from KDIGO Controversies Conference - Kidney International https://t.co/wM1aZwV3To @SENefrologia well represented with @beaff26 @Emor67 #Porrini & @PepaSolerR /// @SLANH_ with @jorgericof & others
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Drs. Furth, Rossing et al. www.kidney-international.org/article/S008...
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference by Drs. Furth, @P_Rossing et al. https://t.co/3P1LW0E6z3 https://t.co/5O8z5FPr7k
RT @RafaelLpezMrqu2: The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outco…
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes Controversies Conference
The relationship between obesity and chronic kidney disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference @Kidney_Int #CKD https://t.co/SF6nCbQP5J
@PineappleRant @its_The_Dr Yes, COVID-19 can exacerbate pre-existing conditions like heart disease, diabetes, obesity, and chronic kidney disease, increasing severe outcomes (CDC, WHO). It also affects major organs: lungs (respiratory issues), heart (clots, myocarditis), kidneys, liver, brain (strokes),
@gomiam @tracheleyspence @myhiddenvalue LOL, the first only had 54 unvaccinated. The study itself indicated "higher rates of morbid obesity and chronic kidney disease" in their unvaccinated group. The other was pregnant woman. It indicates more hospitalizations for Covid in unvaccinated pregnant women.
Obesity is a growing health concern worldwide. It can affect many organs, including the kidneys. Obesity increases the risk of developing #kidneydisease. Read - https://t.co/tPurkr7L3x #health #dialysis #transplant #KidneyTransplant #CKD #SouthWestKidneyInstitute #KidneyHealth https://t.co/wQHiACSwNo
Interesting #NephSky news: This clinical trial 'Study of Retatrutide on Renal Function in Participants With Obesity and Chronic Kidney Disease W/ or W/o or Type 2 Diabetes' is fully enrolled and reports out in Nov 2025. It's using iohexol measured GFR to see if the GFR increase on Reta is real
@agingdoc1 The SLOW-CKD randomized feasibility study presents significant insights into the role of low-energy diets in managing obesity and chronic kidney disease (CKD).
RT @emiluzelac: Chicago Update: Great news from the SUMMIT trial! Tirzepatide is showing impressive results for people with heart failure w…
Chicago Update: Great news from the SUMMIT trial! Tirzepatide is showing impressive results for people with heart failure with preserved ejection fraction (HFpEF), obesity, and chronic kidney disease (CKD). It’s leading to bigger improvements, fewer heart events, and a better
RT @InaquiConQ: Novel results on obesity and chronic kidney disease from Rocio Vila-Bedmar!
RT @InaquiConQ: Novel results on obesity and chronic kidney disease from Rocio Vila-Bedmar!
Novel results on obesity and chronic kidney disease from Rocio Vila-Bedmar!
@siddaramaiah Do you have any idea about how many experts are already working on it globally? If you have the resources, please use them on finding cure for cancer, diabetes, obesity and Chronic Kidney Disease.
“Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.” Publié ce jour dans Nature Medicine. www.nature.com/articles/s41...
今回の動画は、 知らないとヤバい！ 腎臓をキレイにする飲み物・食べ物5選！ https://t.co/kS1By5NQAX https://t.co/fcYTDN12G2
RT @Ryu04196650Ryu: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-bli…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
RT @SENefrologia: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind…
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial: @PepaSolerR @jlgorriz @crz_garrit @chuspuchades @Heerspink79
In clinical trial participants with obesity and chronic kidney disease without diabetes, once-weekly administration of semaglutide 2.4 mg led to a reduction in albuminuria, body weight and systolic blood pressure, according to a paper in @NatureMedicine.
RT @GlobalPHObserv: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes https://t.co/VWLbUwMdJI
RT @GlobalPHObserv: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes https://t.co/VWLbUwMdJI
RT @GlobalPHObserv: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes https://t.co/VWLbUwMdJI
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes https://t.co/VWLbUwMdJI
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial | Nature Medicine https://t.co/zRuxa1Dh0R
RT @drbennisahmed: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blin…
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial clinically meaningful reduction in albuminuria in patients overweight/obesity and non-diabetic CKD https://t.co/6636FIFiET https://t.co/D0yxOQq9N7
RT @KSusztak: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind pla…
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial #science #publication #research #publications https://t.co/m7uwVwKpiQ
RT @KSusztak: Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind pla…
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial 非糖尿病の肥満CKD患者に対するSemaglutideの効果をみたRCT @NatureMedicine (2024) https://t.co/1Ymq35NFUI
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial | @NatureMedicine by Hiddo https://t.co/z6Sl1PME41
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial #Nephrology #Nephpearls @NatureMedicine https://t.co/V2ChfX2yH8
& that’s when the nerd in me go back in forth with the information bc health wise some say that plantbased diets can reduce the risk of chronic diseases that disproportionately affect black people, such as heart disease, cancer, diabetes, obesity, and chronic kidney disease
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @CleClinicNews: One in 7 U.S. adults are estimated to have chronic kidney disease. A new @ClevelandClinic study shows in patients with t…
RT @Weeklyvoice: Weight loss surgery can reduce kidney failure risk in diabetics by 44pc: Study: New Delhi, Sep 20 (VOICE) In people with T…
Weight loss surgery can reduce kidney failure risk in diabetics by 44pc: Study: New Delhi, Sep 20 (VOICE) In people with Type 2 diabetes, obesity, and chronic kidney disease, bariatric or weight loss surgery can significantly protect kidney function and… https://t.co/YwLdgq2D1z
【科学的根拠あり】寝る前1杯飲むだけで腎機能改善！腎臓をキレイにする飲み物5選【クレアチニン｜高い｜老廃物｜高血圧】 https://t.co/YY1dyy2IMR @YouTubeより 腎臓＝下水処理場
https://t.co/GyRJHQgsCx
甘酒と麦茶か…、甘酒は砂糖に気を付けつつ加熱後に飲むべきだね https://t.co/5o0GPlzF6p
今回の動画は、 【科学的根拠あり】 寝る前1杯飲むだけで腎機能改善！ 腎臓をキレイにする飲み物5選 https://t.co/Uf6RSd0ls8 https://t.co/7hMlsEnqP3
RT @AJPEndoMetab: Congratulations to Dr. Zongmiao Jiang and co-authors for winning the #AJPEndoMetab Best Impact Paper!
Congratulations to Dr. Zongmiao Jiang and co-authors for winning the #AJPEndoMetab Best Impact Paper!
#FreeAccessArticle
New Review in #AJPEndoMetab!
#Obesity and chronic #kidney disease (Jiang et al.) - new review in @AJPEndoMetab https://t.co/IP71pHnmTR #CKD #chronickidneydisease #glomerulus #weightloss https://t.co/V9dBltigeW
New paper about obesity-related chronic kidney disease and current therapy approaches: https://t.co/oo16KbeILL
#Obesity and Chronic Kidney Disease (Jiang et al.) - new review in @AJPEndoMetab https://t.co/YtMy32SmZQ #chronickidneydisease #CKD https://t.co/GeW7avSGfI